160 W绿激光汽化术微创治疗高危良性前列腺增生的疗效及安全性
| 作者: |
1王二朋,
1戴廷山,
1王海江,
1范振永,
1詹扬,
1孙骥
1 阜阳市第二人民医院泌尿外科，安徽 阜阳 236015 |
| 通讯: |
王二朋
Email: 56786280@qq.com |
| DOI: | 10.3978/j.issn.2095-6959.2021.08.021 |
摘要
目的：探讨160 W绿激光汽化术(photoselective vaporization of prostate，PVP)治疗高危良性前列腺增生(benign prostatic hyperplasia，BPH)的疗效及安全性。方法：选取阜阳市第二人民医院泌尿外科收治的86例高危BPH患者，区组随机法分为经尿道前列腺电切术(transurethral resection of prostate，TURP)组与160 W PVP组，各43例。对两组围术期指标、国际前列腺症状量表(International Prostate Symptom Scale，IPSS)评分、生活质量(quality of life score，QOL)评分和术后6个月随访情况进行比较。结果：160 W PVP组手术后血红蛋白(hemoglobin，Hb)下降值、术后导管留置时间和住院时间均少于TURP组，差异有统计学意义(P<0.05)；随访结果显示：两组术后6个月IPSS、QOL评分均较术前明显下降，差异有统计学意义(P<0.05)，两组间比较差异无统计学意义(P>0.05)；160 W PVP组总并发症发生率(6.98%)低于TURP组(23.26%)，差异有统计学意义(P<0.05)。结论：160 W PVP是治疗高危BPH的有效术式，具有术中出血少、恢复快和并发症发生率低等优点，手术安全性更佳。
关键词：
高危良性前列腺增生；绿激光系统；激光疗法；近期疗效；安全性
Efficacy and safety of 160 W green laser vaporization for minimally invasive treatment of high-risk benign prostatic hyperplasia
CorrespondingAuthor: WANG Erpeng Email: 56786280@qq.com
DOI: 10.3978/j.issn.2095-6959.2021.08.021
Abstract
Objective: To investigate the efficacy and safety of 160 W green laser vaporization (PVP) and its treatment of high-risk benign prostatic hyperplasia (BPH). Methods: Eighty-six patients with high-risk BPH in Fuyang Second People’s Hospital were selected and randomly divided into transurethral resection of the prostate (TURP) group and 160 W PVP group, 43 cases in each group. The perioperative indicators, International Prostate Symptom Scale (IPSS) score, quality of life (QOL) score and 6-month follow-up of the two groups were compared and analyzed. Results: The decrease of Hb after operation, the postoperative indwelling time of catheter and hospitalization time in the 160 W PVP group were less than those in the TURP group. The difference was statistically significant (P<0.05). The follow-up results showed that the IPSS and QOL scores of the two groups at 6 months after operation were significantly lower than those before operation. The difference was statistically significant (P<0.05), and there was no statistically significant difference between the two groups (P>0.05); the total complication rate of the 160 W PVP group (6.98%) was lower than that of the TURP group (23.26%), and the difference was statistically significant (P<0.05). Conclusion: 160 W PVP is an effective method for the treatment of high-risk benign BPH. It has the advantages of less intraoperative bleeding, rapid recovery, low complication rate and higher safety.
Keywords：
high-risk benign prostatic hyperplasia; green laser system; laser therapy; short-term efficacy; safety